TY - JOUR
T1 - Dietary Flavonoids Vitexin and Isovitexin
T2 - New Insights into Their Functional Roles in Human Health and Disease Prevention
AU - Yan, Weiqi
AU - Cheng, Junying
AU - Xu, Baojun
N1 - Publisher Copyright:
© 2025 by the authors.
Funding Information:
This work was jointly supported by the Guangdong Higher Education Upgrading Plan (2021–2025) (No. of UICR0400015-24B and UICR0400016-24B) at Beijing Normal Hong Kong Baptist University, Zhuhai, China.
PY - 2025/7/21
Y1 - 2025/7/21
N2 - Vitexin and isovitexin are dietary flavonoids widely distributed in food
and medicinal plants. They have attracted increasing attention owing to
their diverse pharmacological activities and favorable safety profiles.
These compounds exhibit therapeutic potential across multiple
biological systems, including the immune, nervous, respiratory,
cardiovascular, and endocrine systems, through antioxidant,
anti-inflammatory, anticancer, antibacterial, and neuroprotective
mechanisms. Although previous reviews have addressed the pharmacological
effects of vitexin and isovitexin, most are limited in scope—either
focusing solely on vitexin or restricted to specific disease models such
as cancer or diabetes. Moreover, some studies are outdated and do not
reflect the recent advances in synthetic modification, green extraction
technologies, and systems pharmacology. This review aims to provide a
comprehensive evaluation of the pharmacological properties,
pharmacokinetics, and clinical relevance of vitexin and isovitexin,
highlighting their potential in disease prevention and treatment. A
literature search was conducted using Web of Science, PubMed, and Google
Scholar, with keywords including “vitexin”, “isovitexin”, “disease”,
and “mechanism”. Here, we summarize the current research on the
pharmacological effects of vitexin and isovitexin in metabolic
disorders, inflammatory diseases, cancer, and neurodegenerative
conditions, focusing on their molecular mechanisms and therapeutic
targets. Furthermore, we discussed their toxicity, bioavailability,
pharmacokinetics, and clinical research findings. Vitexin and isovitexin
hold promise as therapeutic agents or adjuncts for multiple diseases
with potential applications in modern medicine and healthcare. However,
their pharmacological mechanisms, clinical efficacy, and potential
synergistic effects with other therapeutic agents remain unclear.
Further systematic research is needed to clarify molecular targets and
optimize their therapeutic applications.
AB - Vitexin and isovitexin are dietary flavonoids widely distributed in food
and medicinal plants. They have attracted increasing attention owing to
their diverse pharmacological activities and favorable safety profiles.
These compounds exhibit therapeutic potential across multiple
biological systems, including the immune, nervous, respiratory,
cardiovascular, and endocrine systems, through antioxidant,
anti-inflammatory, anticancer, antibacterial, and neuroprotective
mechanisms. Although previous reviews have addressed the pharmacological
effects of vitexin and isovitexin, most are limited in scope—either
focusing solely on vitexin or restricted to specific disease models such
as cancer or diabetes. Moreover, some studies are outdated and do not
reflect the recent advances in synthetic modification, green extraction
technologies, and systems pharmacology. This review aims to provide a
comprehensive evaluation of the pharmacological properties,
pharmacokinetics, and clinical relevance of vitexin and isovitexin,
highlighting their potential in disease prevention and treatment. A
literature search was conducted using Web of Science, PubMed, and Google
Scholar, with keywords including “vitexin”, “isovitexin”, “disease”,
and “mechanism”. Here, we summarize the current research on the
pharmacological effects of vitexin and isovitexin in metabolic
disorders, inflammatory diseases, cancer, and neurodegenerative
conditions, focusing on their molecular mechanisms and therapeutic
targets. Furthermore, we discussed their toxicity, bioavailability,
pharmacokinetics, and clinical research findings. Vitexin and isovitexin
hold promise as therapeutic agents or adjuncts for multiple diseases
with potential applications in modern medicine and healthcare. However,
their pharmacological mechanisms, clinical efficacy, and potential
synergistic effects with other therapeutic agents remain unclear.
Further systematic research is needed to clarify molecular targets and
optimize their therapeutic applications.
KW - vitexin
KW - isovitexin
KW - dietary flavonoid
KW - chronic disease prevention
KW - bioavailability
KW - health promotion
UR - https://www.scopus.com/pages/publications/105011854643
U2 - 10.3390/ijms26146997
DO - 10.3390/ijms26146997
M3 - Review article
AN - SCOPUS:105011854643
SN - 1661-6596
VL - 26
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 14
M1 - 6997
ER -